Puma Biotechnology Financials
| PBYI Stock | USD 5.77 0.18 3.03% |
Puma Biotechnology Stock Summary
Puma Biotechnology competes with Eledon Pharmaceuticals, Abeona Therapeutics, Voyager Therapeutics, Atea Pharmaceuticals, and Arcturus Therapeutics. Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company was founded in 2010 and is headquartered in Los Angeles, California. Puma Biotechnology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 196 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US74587V1070 |
| Business Address | 10880 Wilshire Boulevard, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.pumabiotechnology.com |
| Phone | 424 248 6500 |
| Currency | USD - US Dollar |
Puma Biotechnology Key Financial Ratios
Puma Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Puma Biotechnology's current stock value. Our valuation model uses many indicators to compare Puma Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Puma Biotechnology competition to find correlations between indicators driving Puma Biotechnology's intrinsic value. More Info.Puma Biotechnology is regarded second in return on equity category among its peers. It is considered to be number one stock in return on asset category among its peers reporting about 0.25 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Puma Biotechnology is roughly 4.01 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Puma Biotechnology's earnings, one of the primary drivers of an investment's value.Puma Biotechnology Systematic Risk
Puma Biotechnology's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Puma Biotechnology volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Puma Biotechnology correlated with the market. If Beta is less than 0 Puma Biotechnology generally moves in the opposite direction as compared to the market. If Puma Biotechnology Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Puma Biotechnology is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Puma Biotechnology is generally in the same direction as the market. If Beta > 1 Puma Biotechnology moves generally in the same direction as, but more than the movement of the benchmark.
About Puma Biotechnology Financials
What exactly are Puma Biotechnology Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Puma Biotechnology's income statement, its balance sheet, and the statement of cash flows. Potential Puma Biotechnology investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Puma Biotechnology investors may use each financial statement separately, they are all related. The changes in Puma Biotechnology's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Puma Biotechnology's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Puma Biotechnology Thematic Clasifications
Puma Biotechnology is part of several thematic ideas from Biotech to Cancer Fighters. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasPuma Biotechnology January 4, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Puma Biotechnology help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Puma Biotechnology. We use our internally-developed statistical techniques to arrive at the intrinsic value of Puma Biotechnology based on widely used predictive technical indicators. In general, we focus on analyzing Puma Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Puma Biotechnology's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.73 | |||
| Information Ratio | 0.0556 | |||
| Maximum Drawdown | 43.28 | |||
| Value At Risk | (3.85) | |||
| Potential Upside | 5.81 |
Complementary Tools for Puma Stock analysis
When running Puma Biotechnology's price analysis, check to measure Puma Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Puma Biotechnology is operating at the current time. Most of Puma Biotechnology's value examination focuses on studying past and present price action to predict the probability of Puma Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Puma Biotechnology's price. Additionally, you may evaluate how the addition of Puma Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |